Financial Statements and Related Announcement::Half Yearly Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
02-Nov-2017 21:03:19
Status
New
Announcement Sub Title
Half Yearly Results
Announcement Reference
SG171102OTHRZLM4
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
02/11/2017 17:40:00
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Sub: Outcome of the Board Meeting, November 2, 2017

Ref.: Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR, 2015 )

Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2017.

The said meeting of the Board commenced at 02.00 p.m. and concluded at 5.40 p.m.

The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.

These are also being made available on the website of the Company at www.glenmarkpharma.com.

You are requested to take the same on record.

Additional Details

For Financial Period Ended
30/09/2017

Attachments

SGX_Results_30092017.pdf
Total size =1952K